A randomized, open-label, clinical trial examined the effects of canagliflozin on albuminuria and eGFR decline using an individual pre-intervention eGFR slope.

卡格列净 蛋白尿 医学 随机对照试验 内科学 临床试验 肿瘤科 干预(咨询) 打开标签 泌尿科 肾功能 内分泌学 糖尿病 2型糖尿病 精神科
作者
Satoshi Miyamoto,Hiddo J.L. Heerspink,Dick de Zeeuw,Kota Sakamoto,Michihiro Yoshida,Masao Toyoda,Daisuke Suzuki,Takashi Hatanaka,Tohru Nakamura,Shinji Kamei,Satoshi Murao,Kazuyuki Hida,Shin’ichiro Ando,Hiroaki Akai,Yasushi Takahashi,Munehiro Kitada,Hisashi Sugano,Tomokazu Nunoue,Akihiko Nakamura,Motofumi Sasaki,Tatsuaki Nakatou,Kei Fujimoto,Daiji Kawanami,Takashi Wada,Nobuyuki Miyatake,Hiromi Kuramoto,Kenichi Shikata
出处
期刊:Kidney International [Elsevier BV]
标识
DOI:10.1016/j.kint.2024.08.019
摘要

Demonstrating drug efficacy in slowing kidney disease progression requires large clinical trials when targeting participants with an early stage of chronic kidney disease (CKD). In this randomized, parallel-group, open-labeled trial (CANPIONE study), we assessed the effect of the sodium-glucose cotransporter 2 (SGLT2) inhibitor canagliflozin using the individual's change in estimated glomerular filtration rate (eGFR) slope before (pre-intervention slope) and during treatment (chronic slope). We randomly assigned (1:1) participants with type 2 diabetes, urinary albumin-to-creatinine ratio (UACR) of 50 to under 300 mg/g, and an eGFR of at least 45 ml/min/1.73m2 to receive canagliflozin or guideline-recommended treatment except for SGLT2 inhibitors (control). The first and second primary outcomes were the geometric mean percentage change from baseline in UACR and the change in eGFR slope, respectively. Of 98 randomized participants, 96 received at least one study treatment. The least-squares mean change from baseline in log-transformed geometric mean UACR was significantly greater in the canagliflozin group than the control group (between group-difference, −30.8% (95% confidence interval −42.6 to −16.8). The between-group difference (canagliflozin group – control group) of change in eGFR slope (chronic – pre-intervention) was 4.4 (1.6 to 7.3) ml/min/1.73 m2 per year, which was more pronounced in participants with faster eGFR decline. In summary, canagliflozin reduced albuminuria and the participant-specific natural course of eGFR decline in participants with type 2 diabetes and microalbuminuria. Thus, the CANPIONE study suggests that the within-individual change in eGFR slope may be a novel approach to determine the kidney protective potential of new therapies in early stages of CKD.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小马甲的应助被斯文若血采纳,获得10
1秒前
西梅完成签到,获得积分10
1秒前
1秒前
1秒前
1秒前
yaswer完成签到,获得积分10
1秒前
2秒前
2秒前
sandwich发布了新的文献求助10
2秒前
在水一方的应助被比耶采纳,获得30
2秒前
大模型的应助被波浪蔬菜卷儿采纳,获得10
2秒前
3秒前
耳机杀手完成签到,获得积分10
3秒前
雪山大地发布了新的文献求助10
3秒前
3秒前
那年夏天完成签到,获得积分10
3秒前
3秒前
徐铭蔚发布了新的文献求助10
4秒前
小马甲的应助被哒哒哒采纳,获得10
4秒前
AGAIN关注了科研通微信公众号
4秒前
haibo发布了新的文献求助10
4秒前
汉堡包的应助被孤独的冷安采纳,获得10
4秒前
Linxiang完成签到,获得积分10
5秒前
5秒前
5秒前
dandan完成签到,获得积分10
6秒前
6秒前
笑笑发布了新的文献求助10
7秒前
在水一方的应助被gqzhu采纳,获得10
7秒前
纯真的安萱完成签到 ,获得积分10
8秒前
8秒前
酷炫忆梅发布了新的文献求助10
8秒前
rintoki完成签到,获得积分10
8秒前
8秒前
AllRightReserved完成签到 ,获得积分0
9秒前
无限凛发布了新的文献求助10
9秒前
搞怪建辉发布了新的文献求助30
9秒前
大个的应助被哒哒哒采纳,获得10
9秒前
9秒前
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8163922
求助须知:如何正确求助?哪些是违规求助? 9557995
关于积分的说明 21743022
捐赠科研通 7754548
什么是DOI,文献DOI怎么找? 3428401
关于科研通互助平台的介绍 2553053
邀请新用户注册赠送积分活动 2473008